Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 18/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 11/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 6/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| J-113,397 SCHEMBL29623055 | 1.00 | OPRL1 (1.00) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL12918433 | 1.00 | OPRL1 (1.00) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL1946862 | 1.00 | OPRL1 (1.00) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL29623041 | 1.00 | OPRL1 (1.00) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL4920647 | 1.00 | OPRL1 (1.00) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL6586337 | 1.00 | OPRL1 (1.00) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL4920487 | 0.99 | OPRL1 (0.98) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL16752513 | 0.99 | OPRL1 (0.98) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| J-113,397 SCHEMBL4920476 | 0.99 | OPRL1 (0.98) | OPRL1OPRM1OPRK1OPRD1DRD2 | |
| SCHEMBL4919683 | 0.92 | OPRL1 (0.85) | OPRL1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115296253-B | Self-recovery overvoltage and undervoltage protection circuit | 湖南科技大学 | 2025-05-09 | — | — | CN | claimed |
| CN-117978139-A | Reset delay circuit | 安徽熙泰智能科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-20240050559-A1 | METHOD OF MAKING VIRUS-LIKE PARTICLE | ICOSAVAX, INC. | 2024-02-15 | — | — | US | claimed |
| CN-116234567-A | Method for assembling two-component virus-like particles | Icosavax股份有限公司 | 2023-06-06 | — | — | CN | claimed |
| EP-4161943-A2 | METHOD OF MAKING VIRUS-LIKE PARTICLE | Icosavax, Inc. (US) | 2023-04-12 | — | — | EP | claimed |
| CN-115833837-A | High-speed Flash-SAR hybrid analog-to-digital converter | 大连理工大学 | 2023-03-21 | — | — | CN | claimed |
| CN-115296253-A | Self-recovery type over-voltage and under-voltage protection circuit | 湖南科技大学 | 2022-11-04 | — | — | CN | claimed |
| EP-3500572-B1 | CYTISINE DERIVATIVES FOR THE TREATMENT OF ADDICTION | UNIV BRISTOL (GB) | 2022-10-26 | — | — | EP | claimed |
| CN-114758687-B | Self-adaptive Cache access circuit and implementation method thereof | 南京低功耗芯片技术研究院有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-114758687-A | Self-adaptive Cache access circuit and implementation method thereof | 南京低功耗芯片技术研究院有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-111950565-B | Abstract picture image direction identification method based on feature fusion and naive Bayes | 山西大学 | 2022-05-20 | — | — | CN | claimed |
| CN-111265663-B | Application of orphanin enkephalin receptor specific antagonist in preparation of arrhythmia treatment drug | 郭政 | 2022-04-22 | — | — | CN | claimed |
| US-7557088-B2 | Methods and compositions for treating conditions | NEOPRO LABS, LLC (US) | 2009-07-07 | — | — | US | claimed |
| WO-2026087396-A1 | BIOBASED ADHESIVE COMPOSITION, METHOD FOR OBTAINING SAME AND USE THEREOF AS ADHESIVE | Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (FR) | 2026-04-30 | — | — | WO | disclosed |
| US-12606828-B2 | Aptamers for use in the treatment of Coronaviridae infections | APTA Therapeutics GmbH (DE) | 2026-04-21 | — | — | US | disclosed |
| WO-2026079292-A1 | GLASS, NEAR-INFRARED ABSORPTION CUT-OFF FILTER, AND SOLID-STATE IMAGING ELEMENT | ＡＧＣ株式会社 | 2026-04-16 | — | — | WO | disclosed |
| US-7300947-B2 | N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-11-27 | — | — | US | disclosed |
| US-20070015792-A1 | N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives | MSD K.K. (JP) | 2007-01-18 | — | — | US | disclosed |
| US-20070015792-A1 | N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives | MSD K.K. (JP) | 2007-01-18 | — | — | US | disclosed |
| WO-2005004896-A1 | NOP RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PARKINSON’S DISEASE | UFPEPTIDES S.R.L. (IT) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015792-A1 | N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives | OPRL1, OPRK1, GPR119 | OPRL1 1/4885OPRM1 10/4885OPRK1 2/4885 |
| US-12606828-B2 | Aptamers for use in the treatment of Coronaviridae infections | DNTT, TPT1, TEKT1 | OPRL1 3379/4885OPRM1 2839/4885OPRK1 3313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.